Fundraising Fox

Spark Biomedical

Dallas, US · Founded 2023 · Delaware corporation · 29 employees on LinkedIn · 3 known investors

Spark Biomedical develops wearable neurostimulation devices for bioelectronic medicine applications, primarily targeting mental health, women's health, hemostasis, and pediatrics. The company's FDA-cleared product treats opioid withdrawal and is conducting multiple clinical trials to expand into additional therapeutic areas.

BiotechDigital HealthHardwareHealthtechMedical Devices

Founders & leadership

DPDaniel Powell
Daniel PowellinPresident & Chief Executive Officer
ACAlejandro Covalin, PhD
Alejandro Covalin, PhDinChief Technology Officer
NKNavid Khodaparast, PhD
Navid Khodaparast, PhDinChief Science Officer
AC
Alejandro CovalinChief Technology Officer and Director
NKNavid Khodaparast
Navid KhodaparastChief Science Officer and Director
TC
Ted CostopoulosNamed on SEC filing
CR
Carl R. DeeleyNamed on SEC filing

Investors · 3

Aggie Angel NetworkCollege Station
Pathway to CuresNew York
Wave VenturesreportedHelsinki

Funding

SEC filings, press & company announcements

$31.2M disclosed across 2 rounds · 2023–2025

▶$16.2MraisedMay 2023 · 127 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alejandro CovalinExecutive Officer, Director
  • Navid KhodaparastExecutive Officer, Director
  • Ted CostopoulosDirector
  • Carl R. DeeleyDirector
  • Daniel PowellExecutive Officer, Director
Offering amount
$21.8M
Amount sold
$16.2M
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap
Sparkneuro14 shared keywordsSPARK provides dementia diagnosis support, identifying high-risk members early and offering comprehensive cognitive evaluations to enable earlier intervention. It uses dementia specialists to reduce the workload on primary care physicians, targeting patients and providers in the U.S. dementia care market.
Power13 shared keywordsPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Medscape10 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.

Companies competing with Spark Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 5 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
U.S. ArmyArmyPhase IISTTR2023$1.1M
U.S. ArmyArmyPhase ISTTR2022$172.6K
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$2.5M
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$2.5M
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$217.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Spark Biomedical Awarded Funding from Wellcome Leap for Women’s Health Innovationfinance.yahoo.com · Aug 2025Spark Biomedical Secures $15M Series A To Advance Drug-Free Wearable Neurostimulation Therapiesglobenewswire.com · Apr 2025Dallas' Spark Biomedical Raises $15M Series A to Advance Its Wearable Neurostimulation Therapies » Dallas Innovatesdallasinnovates.com · Apr 2025Spark Biomedical Raises $15M in Series A Fundingfinsmes.com · Apr 2025

Frequently asked questions

What does Spark Biomedical do?
Spark Biomedical develops wearable neurostimulation devices for bioelectronic medicine applications, primarily targeting mental health, women's health, hemostasis, and pediatrics. The company's FDA-cleared product treats opioid withdrawal and is conducting multiple clinical trials to expand into additional therapeutic areas.
Who are Spark Biomedical's investors?
Spark Biomedical's investors include Aggie Angel Network, Pathway to Cures, Wave Ventures.
How much funding has Spark Biomedical raised?
Spark Biomedical has disclosed $31.2M raised across 2 rounds.
Where is Spark Biomedical headquartered?
Spark Biomedical is headquartered in Dallas, US.